Shenzhen Lifotronic Technology Co., Ltd. (688389.SH) has obtained a medical device registration certificate.
Pumen Technology (688389.SH) announced that the company recently received a "Medical Device Registration Certificate (In-Vitro Diagnostic Reagent)" issued by the Drug Administration of Guangdong Province, People's Republic of China. The product name is: Erythropoietin (EPO) Detection Reagent Kit (Electrochemiluminescence Method).
Shenzhen Lifotronic Technology Co., Ltd.(688389.SH) announced that it has recently received a Medical Device Registration Certificate (In vitro diagnostic reagents) issued by the Guangdong Provincial Drug Administration Bureau of the People's Republic of China. The product name is Erythropoietin (EPO) Assay Kit (Electrochemiluminescence).
The Erythropoietin (EPO) Assay Kit (Electrochemiluminescence) obtained in this registration certificate uses a double-antibody sandwich chemiluminescence immunoassay, which has high sensitivity, precision, and other performance characteristics. This further enriches and improves the company's electrochemiluminescence reagent testing menu, and will help enhance the company's market competitiveness in the field of immune diagnostics.
Related Articles
Xiaomi (01810) spent HK$99.9963 million on March 3 to repurchase 3.1564 million shares.
GF SEC(01776): "26 Guangfa 02" inquiry range is 1.30%-2.30%
MNSO (09896) spent 1.9132 million Hong Kong dollars to repurchase 56,600 shares on March 3rd.
Xiaomi (01810) spent HK$99.9963 million on March 3 to repurchase 3.1564 million shares.
GF SEC(01776): "26 Guangfa 02" inquiry range is 1.30%-2.30%
MNSO (09896) spent 1.9132 million Hong Kong dollars to repurchase 56,600 shares on March 3rd.
RECOMMEND
